⏱ 2 min read
Brandon Piper, a 35-year-old from Gobles, Michigan, was sentenced to 21 months in prison for his role in a scheme to import and sell unapproved, misbranded prescription drugs from China. The drugs, including peptides like semaglutide and tirzepatide, were sold to customers in the US through a Canadian website and later through Piper’s own site, www.MilestonePurity.com. The websites claimed the drugs were for research purposes only, but Piper and his co-conspirators knew customers would be using them personally.
The drugs were sold without prescriptions and shipped without adequate directions for use. FDA-approved versions of these drugs carry significant warnings, including the risk of thyroid C-cell tumors. However, the versions sold by Piper omitted these warnings, putting customers at risk of serious or life-threatening adverse effects.
Piper’s sentence was handed down by U.S. District Judge Robert J. Jonker, who stated that the sentence was designed to send a message to Piper and the public about the consequences of ignoring the FDA and the law. The case highlights the dangers of buying prescription drugs from unapproved sources and the importance of following FDA regulations.
The investigation and prosecution of Piper’s case demonstrate the commitment of law enforcement agencies to protecting public health and safety. The FDA and DOJ worked together to bring Piper to justice and shut down the illegal operation.
📋 Key Facts
- Crime: Drug Trafficking
- Defendant: Michigan
- Location: MI
- Source: DOJ Press Release
MORE FEDERAL CRIME NEWS
Drug TraffickingDrug TraffickingDrug TraffickingDrug Trafficking